维里迪安治疗 VRDN
$28.49 −$0.06 (-0.21%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $28.48 -0.04%
开盘$28.66
昨收$28.55
当日区间$27.86 – $29.47
成交量4.50M
市值$3.24B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$284,000.00+278.7% YoY
营业利润-$126.27M-18.3% YoY
净利润-$127.12M-26.2% YoY
摊薄每股收益-$1.05-5.0% YoY
自由现金流-$106.63M-41.4% YoY
经营现金流-$105.32M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-569.7%
净利率-544.1%
净资产收益率-86.9%
资产收益率-46.1%
投入资本回报率-69.5%
流动比率16.95
负债/资产比率39.7%
现金及投资$981.53M
总负债$242.16M
净现金（净负债）$739.37M
营收构成
2026/Q1 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $284,000.00 | $141,000.00 | $70.85M | $132,000.00 | $70.57M |
| 营业总收入 | $284,000.00 | $141,000.00 | $70.85M | $132,000.00 | $70.57M |
| 营业费用 | $126.55M | $116.31M | $434.24M | $122.88M | $110.58M |
| 销售及管理费用 | $54.98M | $38.68M | $95.32M | $33.67M | $24.32M |
| -管理费用 | $54.98M | $38.68M | $95.32M | $33.67M | $24.32M |
| 研发费用 | $71.58M | $77.63M | $338.93M | $89.21M | $86.26M |
| 营业利润 | -$126.27M | -$116.17M | -$363.40M | -$122.75M | -$40.01M |
| 非经营性利息净收入（支出） | $183,000.00 | $4.41M | $22.45M | $4.51M | $4.96M |
| 非经营性利息收入 | $8.49M | $7.87M | $27.40M | $7.79M | $5.52M |
| 非经营性利息支出 | $8.31M | $3.46M | $4.95M | $3.28M | $560,000.00 |
| 其他收入（支出） | -$1.03M | $6.86M | -$1.66M | -$2.12M | $453,000.00 |
| 证券出售收益 | -$1.19M | $7.53M | – | – | – |
| 其他非经营性收入（支出） | $156,000.00 | -$672,000.00 | -$1.66M | -$2.12M | $453,000.00 |
| 税前利润 | -$127.12M | -$104.90M | -$342.60M | -$120.36M | -$34.60M |
| 净利润 | -$127.12M | -$104.90M | -$342.60M | -$120.36M | -$34.60M |
| 持续经营利润 | -$127.12M | -$104.90M | -$342.60M | -$120.36M | -$34.60M |
| 归属母公司净利润 | -$127.12M | -$104.90M | -$342.60M | -$120.36M | -$34.60M |
| 归属普通股股东净利润 | -$127.12M | -$92.03M | -$342.60M | -$161.75M | -$28.17M |
| 基本每股收益 | -$1.05 | -$0.90 | -$3.32 | -$1.08 | -$0.34 |
| 摊薄每股收益 | -$1.05 | -$0.90 | -$3.32 | -$1.08 | -$0.34 |
| 其他优先股股息 | – | -$12.88M | – | – | -$6.43M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.10B | $789.02M | $899.42M | $899.42M | $577.14M |
| 流动资产合计 | $1.08B | $784.74M | $894.23M | $894.23M | $571.91M |
| 现金及现金等价物与短期投资 | $981.53M | $762.18M | $874.65M | $874.65M | $490.90M |
| -现金及现金等价物 | $164.99M | $176.35M | $212.38M | $212.38M | $169.65M |
| -短期投资 | $816.54M | $585.84M | $662.27M | $662.27M | $321.25M |
| 应收款 | $75.00M | – | – | – | $70.00M |
| -其他应收款 | $75.00M | – | – | – | $70.00M |
| 其他流动资产 | $24.74M | $22.56M | $19.58M | $19.58M | $11.01M |
| 非流动资产合计 | $15.96M | $4.27M | $5.19M | $5.19M | $5.23M |
| 固定资产净值 | $4.85M | $3.39M | $3.65M | $3.65M | $3.71M |
| -固定资产原值 | $4.85M | $3.39M | $4.87M | $4.87M | $3.71M |
| 商誉及其他无形资产 | $10.00M | – | – | – | – |
| 其他非流动资产 | $1.11M | $888,000.00 | $1.54M | $1.54M | $1.52M |
| 负债合计 | $435.14M | $153.01M | $177.25M | $177.25M | $74.17M |
| 流动负债合计 | $63.79M | $51.81M | $70.70M | $70.70M | $50.70M |
| 应付款 | $8.65M | $13.31M | $8.68M | $8.68M | $10.06M |
| -应付账款 | $8.65M | $13.31M | $8.68M | $8.68M | $10.06M |
| 一年内应计费用 | $40.07M | $29.12M | $41.24M | $41.24M | $28.82M |
| 短期债务及融资租赁负债 | $722,000.00 | $738,000.00 | $753,000.00 | $753,000.00 | $730,000.00 |
| -一年内到期融资租赁负债 | $722,000.00 | $738,000.00 | $753,000.00 | $753,000.00 | $730,000.00 |
| 一年内递延负债 | $181,000.00 | $274,000.00 | $367,000.00 | $367,000.00 | $372,000.00 |
| 非流动负债合计 | $371.34M | $101.20M | $106.56M | $106.56M | $23.47M |
| 长期债务及融资租赁负债 | $242.16M | $50.44M | $49.94M | $49.94M | $20.89M |
| -长期债务 | $242.16M | $50.44M | $49.94M | $49.94M | $20.89M |
| 衍生产品负债 | $13.69M | $12.50M | $20.03M | $20.03M | – |
| 一年以上递延负债 | $113.64M | $36.09M | $34.24M | $34.24M | – |
| 其他非流动负债 | $1.85M | $2.18M | $2.34M | $2.34M | $2.58M |
| 股东权益合计 | $662.10M | $636.01M | $722.17M | $722.17M | $502.97M |
| 股东权益 | $662.10M | $636.01M | $722.17M | $722.17M | $502.97M |
| 股本 | $99.16M | $133.08M | $133.07M | $133.07M | $189.71M |
| -普通股 | $1.13M | $1.03M | $1.02M | $1.02M | $822,000.00 |
| -优先股 | $98.02M | $132.06M | $132.06M | $132.06M | $188.89M |
| 资本公积 | $2.13B | $1.95B | $1.93B | $1.93B | $1.53B |
| 留存收益 | -$1.57B | -$1.44B | -$1.34B | -$1.34B | -$1.22B |
| 不影响留存收益的损益 | -$1.15M | -$558,000.00 | $447,000.00 | $447,000.00 | $363,000.00 |
| -累计折旧 | – | – | -$1.22M | -$1.22M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$105.32M | -$119.65M | -$276.39M | -$23.75M | -$84.61M |
| 持续经营经营活动现金流净额 | -$105.32M | -$119.65M | -$276.39M | -$23.75M | -$84.61M |
| 持续经营净利润 | -$127.12M | -$104.90M | -$342.60M | -$120.36M | -$34.60M |
| 持续经营损益 | $5.64M | -$7.53M | $700,000.00 | – | – |
| 折旧、折耗与摊销 | $117,000.00 | $121,000.00 | $460,000.00 | $120,000.00 | $110,000.00 |
| 其他非现金项目 | $2.34M | $2.51M | $4.47M | $4.20M | $89,000.00 |
| 营运资金变动 | -$1.84M | -$21.39M | $23.03M | $81.35M | -$60.33M |
| -预付资产变动 | -$2.40M | -$2.33M | $262,000.00 | -$8.59M | $3.37M |
| -应付账款及应计费用变动 | $909,000.00 | -$19.06M | $22.77M | $19.94M | $6.16M |
| 投资活动现金流净额 | -$231.16M | $77.26M | -$37.56M | -$339.42M | $126.08M |
| 持续经营投资活动现金流净额 | -$231.16M | $77.26M | -$37.56M | -$339.42M | $126.08M |
| 固定资产购置及出售净额 | -$1.31M | -$23,000.00 | -$495,000.00 | -$240,000.00 | -$127,000.00 |
| 投资购置及出售净额 | -$229.85M | $77.28M | -$37.07M | -$339.18M | $126.20M |
| 筹资活动现金流 | $325.12M | $6.36M | $426.74M | $405.91M | $10.86M |
| 持续经营筹资活动现金流净额 | $325.12M | $6.36M | $426.74M | $405.91M | $10.86M |
| 普通股发行净额 | $143.75M | $0.00 | $352.20M | $337.29M | $9.96M |
| 股票期权行使所得 | $1.85M | $6.36M | $14.79M | $8.45M | $1.11M |
| 期末现金余额 | $164.99M | $176.35M | $212.38M | $212.38M | $169.65M |
| 现金净变动 | -$11.36M | -$36.04M | $112.79M | $42.74M | $52.32M |
| 期初现金余额 | $176.35M | $212.38M | $99.59M | $169.65M | $117.32M |
| 自由现金流 | -$106.63M | -$119.68M | -$276.89M | -$23.99M | -$84.74M |
| 债务发行及偿还净额 | – | – | $28.88M | – | – |
| 优先股发行净额 | – | – | $0.00 | $0.00 | – |
| 其他筹资费用净额 | – | – | $30.88M | $31.30M | -$209,000.00 |
暂无评论——快来第一个聊聊 VRDN。